Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00046813 · ClinicalTrials.gov registry record · Phase 4
Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1
A Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).
- Terminated
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT00046813 is a Phase 4 study that was terminated before completion, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 100 participants.
The verdict
NCT00046813, a Phase 4 study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to test the use of High-Dose versus Regular-Dose Nicotine Patch for Nicotine Dependence in Individuals with Schizophrenia or Schizoaffective Disorder
Interventions
- DRUG Nicotine patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2001-08 |
| Est. Completion | 2005-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00046813
The ClinicalTrials.gov registry entry for NCT00046813 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nicotine patch is the first listed.
NCT00046813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00046813 about?
NCT00046813 is a clinical study titled "Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1". The purpose of this study is to test the use of High-Dose versus Regular-Dose Nicotine Patch for Nicotine Dependence in Individuals with Schizophrenia or Schizoaffective Disorder
What is the current status of trial NCT00046813?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2001-08. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00046813?
The interventions under investigation include: Nicotine patch (DRUG).
Who is sponsoring clinical trial NCT00046813?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.